CLINICAL_TRIALS
trial_result
· 2023-04-10
Clinical Trial Update: MEthylene Blue In Patients With Acquired Methemoglobinemia [Phase 4]
Summary
A Phase 4 clinical trial evaluating methylene blue in patients with acquired methemoglobinemia has been completed with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Provepharm SAS | Conditions: Acquired Methaemoglobinaemia | Phase 4 | Status: COMPLETED | Results posted: 2023-04-10